AbCellera (ABCL) Misses Q1 EPS by 1c, Revenue Beats

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to AbCellera (ABCL) Misses Q1 EPS by 1c, Revenue Beats

AbCellera Reports Q1 2021 Business Results

May 13, 2021 4:05 PM EDT

Total revenue of $203 million, up from $5 million in Q1 2020 Total programs under contract of 119, up 63% year-over-year EPS of $0.43 (basic) and $0.37 (diluted) compared to $0.01 loss per share in Q1 2020

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced financial results for the first quarter of 2021.

Our partnership business continued to thrive in the first quarter of 2021, expanding our diversified program portfolio through collaborations with both new and existing... More